JPRN-jRCTs041180086已完成4 期
Clinical study about the safety of Orexin receptor antagonist Suvorexant for severe sleep apnea syndrome - Clinical study about the safety of Suvorexant for severe sleep apnea syndrome
Imaizumi Kazuyoshi0 个研究点目标入组 30 人开始时间: 2019年3月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
There was no significant difference in the AHI of patients with severe sleep apnea before and after taking Suvorexant.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •The patient who received enough explanation about this study, and provides agreement in the document.
排除标准
- •The patient 19 years or younger at the time of the agreement acquisition
研究者
相似试验
已完成
不适用
Clinical study about the safety of Orexin receptor antagonist Suvorexant for severe sleep apnea syndromeSleep Apnea SyndromeJPRN-UMIN000027645Fujita Health University respiratory medicine department30
已完成
不适用
Efficacy and safety of orexin receptor antagonist as premedicatioJPRN-UMIN000019977Institute of Biomedical Sciences Tokushima University Graduate School Department of Anesthesiology30
已完成
4 期
Suvorexant and Sleep/Delirium in ICU PatientsSleep FragmentationSleep Initiation and Maintenance DisordersPostoperative DeliriumInsomniaNCT04092894Beth Israel Deaconess Medical Center100
招募中
不适用
Clinical usefulness of orexin receptore antagonist for insomnia during hospitalization in an acute care hospitalinsomniaJPRN-jRCT1031220318Saito Taeko50
已完成
4 期
Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress DisorderPosttraumatic Stress DisorderNCT02849548Howard University27